Viewing Study NCT00003034


Ignite Creation Date: 2025-12-25 @ 2:34 AM
Ignite Modification Date: 2026-03-07 @ 9:30 PM
Study NCT ID: NCT00003034
Status: UNKNOWN
Last Update Posted: 2013-11-06
First Post: 1999-11-01
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: ONCONASE Plus Doxorubicin Versus Doxorubicin Alone For Patients With Malignant Pleural or Peritoneal Mesothelioma Who Have Had No More Than One Prior Chemotherapy Regimen
Sponsor: Alfacell
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 1997-05
Start Date Type: None
Primary Completion Date: 2008-02
Primary Completion Date Type: ESTIMATED
Completion Date: None
Completion Date Type: None
First Submit Date: 1999-11-01
First Submit QC Date: None
Study First Post Date: 2003-01-27
Study First Post Date Type: ESTIMATED
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2013-11-05
Last Update Post Date: 2013-11-06
Last Update Post Date Type: ESTIMATED